Main Article Content
Purpose: To study the clinical features, treatment and outcome of ocular cytomegalovirus (CMV) infection.
Methods: Retrospective case series. Medical records of patients who had ocular CMV infection treated at Thammasat university hospital, Thailand from January 2015 to May 2017 were included. Clinical features, treatments and outcomes were analyzed.
Results: Forty-one patients were diagnosed with ocular CMV diseases including infection in immunocompetent patients (n=25, 61%) and infection in immunocompromised cases (n=16, 39%). Among the immunocompetent group, anterior uveitis was the most common manifestation (n=22, 88%). Posner Schlossman syndrome (n=14, 56%) was majority of CMV anterior uveitis. Patients with CMV anterior uveitis had iris atrophy in 90.5% of cases, increased intraocular pressure in 88% of cases, decreased endothelial cell count in 38.1% of cases and coin-shaped lesions in 27.3% of cases. Anti-viral therapy was administered in 88% of cases and 64% of cases needed long-term topical corticosteroids. Most immunocompromised patients were diagnosed with CMV retinitis (93.8%). Almost all patients (n=14, 87.5%) were HIV infection. Immune recovery uveitis was developed in 20%. Five cases (31.3%) of CMV retinitis received intravenous ganciclovir with adjunctive intravitreal injections of ganciclovir while 68.8% of cases were treated with only intravitreal injections of ganciclovir. Most patients well responded to treatment with the mortality rate of 6.3%.
Conclusions: Cytomegalovirus can infect both immunocompetent and immunocompromised host with variety of clinical features. Anterior uveitis was common in immunocompetent cases while retinitis was common in immunocompromised patients.
Conflicts of interest: There is no conflicting relationship exists for any author.
Keywords: Cytomegalovirus, anterior uveitis, retinitis, endotheliitis
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
1. Ausayakhun S, Keenan JD, Ausayakhun S, Jirawison C, Khouri CM, Skalet AH, et al. Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol. 2012;153(5):923-31 e1.
2. Pathanapitoon K, Tesavibul N, Choopong P, Boonsopon S, Kongyai N, Ausayakhun S, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013;131(5):638-45.
3. Colby DJ, Vo DQ, Teoh SC, Tam NT, Liem NT, Lu D, et al. Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam. Int J STD AIDS. 2014;25(7):516-22.
4. Huang G, Jiang Q, Li M, Lu Y, Wang Z. Retrospective study of cytomegalovirus retinitis complicated with acquired immunodeficiency syndrome. Int J Clin Exp Med. 2015;8(6):9537-42.
5. Kongyai N, Sirirungsi W, Pathanapitoon K, Tananuvat N, Kunavisarut P, Leechanachai P, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond). 2012;26(4):529-34.
6. Kongyai N, Pathanapitoon K, Sirirungsi W, Kunavisarut P, de Groot-Mijnes JD, Rothova A. Infectious causes of posterior uveitis and panuveitis in Thailand. Jpn J Ophthalmol. 2012;56(4):390-5.
7. Yoshida A, Obata H, Kawashima H. Cytomegalovirus Uveitis with Hypopyon Mimicking Bacterial Endophthalmitis. Case Rep Ophthalmol Med. 2015;2015:489813.
8. Pathanapitoon K, Ausayakhun S, Kunavisarut P, Wattananikorn S, Ausayakhun S, Leeungurastien T, et al. Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Retina. 2007;27(5):635-40.
9. Shi Y, Lu H, He T, Yang Y, Liu L, Zhang R, et al. Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in Shanghai, China. BMC Infect Dis. 2011;11:326.
10. Leenasirimakul P, Liu Y, Jirawison C, Khienprasit N, Kamphaengkham S, Ausayakhun S, et al. Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare. Br J Ophthalmol. 2016;100(8):1017-21.
11. Ford N, Shubber Z, Saranchuk P, Pathai S, Durier N, O'Brien DP, et al. Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis. 2013;57(9):1351-61.
12. Lamichhane G, Shah DN, Sharma S, Chaudhary M. Ocular manifestations in HIV/AIDS cases in Nepal. Nepal J Ophthalmol. 2010;2(1):45-50.
13. Liu Y, Chen AS, Kamphaengkham S, Leenasirimakul P, Jirawison C, Ausayakhun S, et al. Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis. PLoS One. 2016;11(10):e0165564.
14. Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, et al. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 2007;4(12):e334.
15. Heiden D, Saranchuk P. CMV retinitis in China and SE Asia: the way forward. BMC Infect Dis. 2011;11:327.
16. Takase H, Kubono R, Terada Y, Imai A, Fukuda S, Tomita M, et al. Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol. 2014;58(6):473-82.
17. Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145(5):834-40.
18. Alfawaz A. Cytomegalovirus-related corneal endotheliitis: A review article. Saudi J Ophthalmol. 2013;27(1):47-9.
19. Woo JH, Lim WK, Ho SL, Teoh SC. Characteristics of Cytomegalovirus Uveitis in Immunocompetent Patients. Ocul Immunol Inflamm. 2015;23(5):378-83.
20. Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883-9 e1.
21. Koizumi N, Inatomi T, Suzuki T, Shiraishi A, Ohashi Y, Kandori M, et al. Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol. 2015;99(1):54-8.
22. Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94(12):1648-52.
23. Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006;113(4):684-94.
24. Urban B, Bakunowicz-Lazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediators Inflamm. 2014;2014:971417.
25. Accorinti M, Gilardi M, Pirraglia MP, Amorelli GM, Nardella C, Abicca I, et al. Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients. Graefes Arch Clin Exp Ophthalmol. 2014;252(11):1817-24.
26. Yen M, Chen J, Ausayakhun S, Kunavisarut P, Vichitvejpaisal P, Ausayakhun S, et al. Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting. Am J Ophthalmol. 2015;159(1):185-92.